Q2 2014

Filed Aug 15, 2014 · 10-Q · 46 days after period end · 0001144204-14-050484

Q2 2014 · 10-Q

Revenue

$0.00

−100.0% vs Q2 2013

Net Income

-$25.87M

N/M vs Q2 2013

EPS Diluted

-$0.45

N/M vs Q2 2013

Operating Income-$25,427,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	$0.00	$272.00K	$330.00K	$0.00
Net Income	-$25.87M	-$11.59M	-$10.15M	-$12.33M
EPS Diluted	-$0.45	-$0.40	-$0.06	-$0.15

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR